J&J Vaccine Far Less Effective Against Delta and Lambda Variants, Study Says

Johnson & Johnson’s (J&J) single-dose vaccine is far less effective against the Delta and Lambda strains of the SARS-CoV-2 virus than against the original coronavirus, researchers at New York University (NYU) reported.
Source: Drug Industry Daily